{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:31Z","timestamp":1786982191944,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03919-9","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T07:14:16Z","timestamp":1722410056000},"page":"943-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mendelian randomization study of inflammatory bowel disease and type 1 diabetes"],"prefix":"10.1007","volume":"86","author":[{"given":"Jing-Yi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Zhe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ru","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Yun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5660-0468","authenticated-orcid":false,"given":"Chang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"3919_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"G.G. Kaplan, J.W. Windsor, The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 18, 56\u201366 (2021). https:\/\/doi.org\/10.1038\/s41575-020-00360-x","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"3919_CR2","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cgh.2020.01.028","volume":"18","author":"AN Ananthakrishnan","year":"2020","unstructured":"A.N. Ananthakrishnan, G.G. Kaplan, S.C. Ng, Changing global epidemiology of inflammatory bowel diseases: sustaining health care delivery into the 21st century. Clin. Gastroenterol. Hepatol. 18, 1252\u20131260 (2020). https:\/\/doi.org\/10.1016\/j.cgh.2020.01.028","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"3919_CR3","doi-asserted-by":"publisher","first-page":"175628482211153","DOI":"10.1177\/17562848221115312","volume":"15","author":"C Bezzio","year":"2022","unstructured":"C. Bezzio, C. Della Corte, M. Vernero, I. Di Luna, G. Manes, S. Saibeni, Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations. Ther. Adv. Gastroenterol. 15, 17562848221115312 (2022). https:\/\/doi.org\/10.1177\/17562848221115312","journal-title":"Ther. Adv. Gastroenterol."},{"key":"3919_CR4","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/AITC202203150","volume":"175","author":"FZ Syed","year":"2022","unstructured":"F.Z. Syed, Type 1 diabetes mellitus. Ann. Intern Med 175, ITC33\u2013ITC48 (2022). https:\/\/doi.org\/10.7326\/AITC202203150","journal-title":"Ann. Intern Med"},{"key":"3919_CR5","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.2337\/diabetes.51.12.3353","volume":"51","author":"EA Gale","year":"2002","unstructured":"E.A. Gale, The rise of childhood type 1 diabetes in the 20th century. Diabetes 51, 3353\u20133361 (2002). https:\/\/doi.org\/10.2337\/diabetes.51.12.3353","journal-title":"Diabetes"},{"key":"3919_CR6","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1053\/j.gastro.2015.07.065","volume":"149","author":"C Huang","year":"2015","unstructured":"C. Huang, T. Haritunians, D.T. Okou et al. Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans. Gastroenterology 149, 1575\u20131586 (2015). https:\/\/doi.org\/10.1053\/j.gastro.2015.07.065","journal-title":"Gastroenterology"},{"key":"3919_CR7","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/gut.2009.199679","volume":"60","author":"CW Lees","year":"2011","unstructured":"C.W. Lees, J.C. Barrett, M. Parkes, J. Satsangi, New IBD genetics: common pathways with other diseases. Gut 60, 1739\u20131753 (2011). https:\/\/doi.org\/10.1136\/gut.2009.199679","journal-title":"Gut"},{"key":"3919_CR8","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/hmg\/ddq078","volume":"19","author":"K Wang","year":"2010","unstructured":"K. Wang, R. Baldassano, H. Zhang et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum. Mol. Genet 19, 2059\u20132067 (2010). https:\/\/doi.org\/10.1093\/hmg\/ddq078","journal-title":"Hum. Mol. Genet"},{"key":"3919_CR9","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/asn.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"P. Sekula, M.F. Del Greco, C. Pattaro, A. K\u00f6ttgen, Mendelian randomization as an approach to assess causality using observational data. J. Am. Soc. Nephrol. 27, 3253\u20133265 (2016). https:\/\/doi.org\/10.1681\/asn.2016010098","journal-title":"J. Am. Soc. Nephrol."},{"key":"3919_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ije\/dyv108","volume":"44","author":"S Burgess","year":"2015","unstructured":"S. Burgess, N.J. Timpson, S. Ebrahim, G. Davey Smith, Mendelian randomization: where are we now and where are we going? Int. J. Epidemiol. 44, 379\u2013388 (2015). https:\/\/doi.org\/10.1093\/ije\/dyv108","journal-title":"Int. J. Epidemiol."},{"key":"3919_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.puhe.2016.12.033","volume":"145","author":"V Gupta","year":"2017","unstructured":"V. Gupta, G.K. Walia, M.P. Sachdeva, Mendelian randomization\u2019: an approach for exploring causal relations in epidemiology. Public Health 145, 113\u2013119 (2017). https:\/\/doi.org\/10.1016\/j.puhe.2016.12.033","journal-title":"Public Health"},{"key":"3919_CR12","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1093\/cvr\/cvy045","volume":"114","author":"M Benn","year":"2018","unstructured":"M. Benn, B.G. Nordestgaard, From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment. Cardiovasc Res. 114, 1192\u20131208 (2018). https:\/\/doi.org\/10.1093\/cvr\/cvy045","journal-title":"Cardiovasc Res."},{"key":"3919_CR13","doi-asserted-by":"publisher","unstructured":"Saadh M.J., Pal R.S., Arias-Gonzales J.L., et al. A Mendelian randomization analysis investigates causal associations between inflammatory bowel diseases and variable risk factors. Nutrients. 2023;15 https:\/\/doi.org\/10.3390\/nu15051202","DOI":"10.3390\/nu15051202"},{"key":"3919_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"J.Z. Liu, S. van Sommeren, H. Huang et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet 47, 979\u2013986 (2015). https:\/\/doi.org\/10.1038\/ng.3359","journal-title":"Nat. Genet"},{"key":"3919_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamapsychiatry.2018.4175","volume":"76","author":"KW Choi","year":"2019","unstructured":"K.W. Choi, C.Y. Chen, M.B. Stein et al. Assessment of bidirectional relationships between physical activity and depression among adults: a 2-sample Mendelian randomization study. JAMA Psychiatry 76, 399\u2013408 (2019). https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.4175","journal-title":"JAMA Psychiatry"},{"key":"3919_CR16","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1002\/ijc.34214","volume":"151","author":"Q Wang","year":"2022","unstructured":"Q. Wang, Q. Shi, J. Lu, Z. Wang, J. Hou, Causal relationships between inflammatory factors and multiple myeloma: a bidirectional Mendelian randomization study. Int J. Cancer 151, 1750\u20131759 (2022). https:\/\/doi.org\/10.1002\/ijc.34214","journal-title":"Int J. Cancer"},{"key":"3919_CR17","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"N.M. Davies, M.V. Holmes, G. Davey Smith, Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362, k601 (2018). https:\/\/doi.org\/10.1136\/bmj.k601","journal-title":"BMJ"},{"key":"3919_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"J. Bowden, G. Davey Smith, S. Burgess, Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J. Epidemiol. 44, 512\u2013525 (2015). https:\/\/doi.org\/10.1093\/ije\/dyv080","journal-title":"Int J. Epidemiol."},{"key":"3919_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"J. Bowden, G. Davey Smith, P.C. Haycock, S. Burgess, Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 40, 304\u2013314 (2016). https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol."},{"key":"3919_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"J.P. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman, Measuring inconsistency in meta-analyses. BMJ 327, 557\u2013560 (2003). https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"3919_CR21","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"F.P. Hartwig, G. Davey Smith, J. Bowden, Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J. Epidemiol. 46, 1985\u20131998 (2017). https:\/\/doi.org\/10.1093\/ije\/dyx102","journal-title":"Int J. Epidemiol."},{"key":"3919_CR22","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.3390\/nu14183683","volume":"14","author":"J Xu","year":"2022","unstructured":"J. Xu, S. Zhang, Y. Tian et al. Genetic causal association between iron status and osteoarthritis: a two-sample Mendelian randomization. Nutrients 14, 3683 (2022). https:\/\/doi.org\/10.3390\/nu14183683","journal-title":"Nutrients"},{"key":"3919_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"L. Jostins, S. Ripke, R.K. Weersma et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119\u2013124 (2012). https:\/\/doi.org\/10.1038\/nature11582","journal-title":"Nature"},{"key":"3919_CR24","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2217\/imt.13.130","volume":"5","author":"A Gjymishka","year":"2013","unstructured":"A. Gjymishka, R.M. Coman, T.M. Brusko, S.C. Glover, Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes. Immunotherapy 5, 1357\u20131366 (2013). https:\/\/doi.org\/10.2217\/imt.13.130","journal-title":"Immunotherapy"},{"key":"3919_CR25","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3390\/nu12051434","volume":"12","author":"A Verdugo-Meza","year":"2020","unstructured":"A. Verdugo-Meza, J. Ye, H. Dadlani, S. Ghosh, D.L. Gibson, Connecting the dots between inflammatory bowel disease and metabolic syndrome: a focus on gut-derived metabolites. Nutrients 12, 1434 (2020). https:\/\/doi.org\/10.3390\/nu12051434","journal-title":"Nutrients"},{"key":"3919_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fimmu.2016.00154","volume":"7","author":"T Zietek","year":"2016","unstructured":"T. Zietek, E. Rath, Inflammation meets metabolic disease: gut feeling mediated by GLP-1. Front Immunol. 7, 154 (2016). https:\/\/doi.org\/10.3389\/fimmu.2016.00154","journal-title":"Front Immunol."},{"key":"3919_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/dom.12165","volume":"15","author":"D Rondas","year":"2013","unstructured":"D. Rondas, W. D\u2019Hertog, L. Overbergh, C. Mathieu, Glucagon-like peptide-1: modulator of beta-cell dysfunction and death. Diab. Obes. Metab. 15, 185\u2013192 (2013). https:\/\/doi.org\/10.1111\/dom.12165","journal-title":"Diab. Obes. Metab."},{"key":"3919_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","volume":"8","author":"S Massironi","year":"2023","unstructured":"S. Massironi, C. Vigano, A. Palermo et al. Inflammation and malnutrition in inflammatory bowel disease. Lancet Gastroenterol. Hepatol. 8, 579\u2013590 (2023). https:\/\/doi.org\/10.1016\/S2468-1253(23)00011-0","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"3919_CR29","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1053\/j.gastro.2021.11.015","volume":"162","author":"AF Di\u2019Narzo","year":"2022","unstructured":"A.F. Di\u2019Narzo, S.M. Houten, R. Kosoy et al. Integrative analysis of the inflammatory bowel disease serum metabolome improves our understanding of genetic etiology and points to novel putative therapeutic targets. Gastroenterology 162, 828\u201382 (2022). https:\/\/doi.org\/10.1053\/j.gastro.2021.11.015","journal-title":"Gastroenterology"},{"key":"3919_CR30","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1097\/MIB.0000000000000763","volume":"22","author":"B Click","year":"2016","unstructured":"B. Click, C. Ramos Rivers, I.E. Koutroubakis et al. Demographic and clinical predictors of high healthcare use in patients with inflammatory bowel disease. Inflamm. Bowel. Dis. 22, 1442\u20131449 (2016). https:\/\/doi.org\/10.1097\/MIB.0000000000000763","journal-title":"Inflamm. Bowel. Dis."},{"issue":"5","key":"3919_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jped.2018.10.003","volume":"95","author":"C Andrade","year":"2019","unstructured":"C. Andrade, C.A.D. Alves, Relationship between bullying and type 1 diabetes mellitus in children and adolescents: a systematic review. J. Pediatr. 95(5), 509\u2013518 (2019). https:\/\/doi.org\/10.1016\/j.jped.2018.10.003","journal-title":"J. Pediatr."},{"key":"3919_CR32","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s00125-018-4550-1","volume":"61","author":"KH Allin","year":"2018","unstructured":"K.H. Allin, V. Tremaroli, R. Caesar et al. Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia 61, 810\u2013820 (2018). https:\/\/doi.org\/10.1007\/s00125-018-4550-1","journal-title":"Diabetologia"},{"key":"3919_CR33","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41591-018-0164-x","volume":"24","author":"Y He","year":"2018","unstructured":"Y. He, W. Wu, H.M. Zheng et al. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat. Med. 24, 1532\u20131535 (2018). https:\/\/doi.org\/10.1038\/s41591-018-0164-x","journal-title":"Nat. Med."},{"key":"3919_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"J. Lloyd-Price, C. Arze, A.N. Ananthakrishnan et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019). https:\/\/doi.org\/10.1038\/s41586-019-1237-9","journal-title":"Nature"},{"key":"3919_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.15403\/jgld-798","volume":"29","author":"S Lu","year":"2020","unstructured":"S. Lu, J. Gong, Y. Tan, D. Liu, Epidemiologic association between inflammatory bowel diseases and type 1 diabetes mellitus: a meta-analysis. J. Gastrointestin Liver Dis. 29, 407\u2013413 (2020). https:\/\/doi.org\/10.15403\/jgld-798","journal-title":"J. Gastrointestin Liver Dis."},{"issue":"33","key":"3919_CR36","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","volume":"23","author":"ML Halling","year":"2017","unstructured":"M.L. Halling, J. Kjeldsen, T. Knudsen, J. Nielsen, L.K. Hansen, Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J. Gastroenterol. 23(33), 6137\u20136146 (2017). https:\/\/doi.org\/10.3748\/wjg.v23.i33.6137","journal-title":"World J. Gastroenterol."},{"key":"3919_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.crohns.2012.02.021","volume":"7","author":"LJ Virta","year":"2013","unstructured":"L.J. Virta, K.L. Kolho, The risk of contracting pediatric inflammatory bowel disease in children with celiac disease, epilepsy, juvenile arthritis and type 1 diabetes-a nationwide study. J. Crohns Colitis 7, 53\u201357 (2013). https:\/\/doi.org\/10.1016\/j.crohns.2012.02.021","journal-title":"J. Crohns Colitis"},{"key":"3919_CR38","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/MEG.0000000000000891","volume":"29","author":"C Bahler","year":"2017","unstructured":"C. Bahler, A.M. Schoepfer, S.R. Vavricka, B. Brungger, O. Reich, Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland. Eur. J. Gastroenterol. Hepatol. 29, 916\u2013925 (2017). https:\/\/doi.org\/10.1097\/MEG.0000000000000891","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"3919_CR39","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1572-0241.2007.01215.x","volume":"102","author":"X Weng","year":"2007","unstructured":"X. Weng, L. Liu, L.F. Barcellos, J.E. Allison, L.J. Herrinton, Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Am. J. Gastroenterol. 102, 1429\u20131435 (2007). https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01215.x","journal-title":"Am. J. Gastroenterol."},{"key":"3919_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15585\/mmwr.mm6706a4","volume":"67","author":"F Xu","year":"2018","unstructured":"F. Xu, J.M. Dahlhamer, E.P. Zammitti, A.G. Wheaton, J.B. Croft, Health-risk behaviors and chronic conditions among adults with inflammatory bowel disease - United States, 2015 and 2016. MMWR Morb. Mortal. Wkly Rep. 67, 190\u2013195 (2018). https:\/\/doi.org\/10.15585\/mmwr.mm6706a4","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"3919_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/jcm8030343","volume":"8","author":"EA Kang","year":"2019","unstructured":"E.A. Kang, K. Han, J. Chun et al. Increased risk of diabetes in inflammatory bowel disease patients: a nationwide population-based study in Korea. J. Clin. Med 8, 343 (2019). https:\/\/doi.org\/10.3390\/jcm8030343","journal-title":"J. Clin. Med"},{"key":"3919_CR42","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/archdischild-2011-300633","volume":"96","author":"MD Kappelman","year":"2011","unstructured":"M.D. Kappelman, J.A. Galanko, C.Q. Porter, R.S. Sandler, Association of paediatric inflammatory bowel disease with other immune-mediated diseases. Arch. Dis. Child 96, 1042\u20131046 (2011). https:\/\/doi.org\/10.1136\/archdischild-2011-300633","journal-title":"Arch. Dis. Child"},{"key":"3919_CR43","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/apa.15643","volume":"110","author":"H Jasser-Nitsche","year":"2021","unstructured":"H. Jasser-Nitsche, S. Bechtold-Dalla Pozza, E. Binder et al. Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes. Acta Paediatr. 110, 1353\u20131358 (2021). https:\/\/doi.org\/10.1111\/apa.15643","journal-title":"Acta Paediatr."},{"key":"3919_CR44","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/ibd\/izz305","volume":"26","author":"H Din","year":"2020","unstructured":"H. Din, A.J. Anderson, C. Ramos Rivers et al. Disease characteristics and severity in patients with inflammatory bowel disease with coexistent diabetes mellitus. Inflamm. Bowel Dis. 26, 1436\u20131442 (2020). https:\/\/doi.org\/10.1093\/ibd\/izz305","journal-title":"Inflamm. Bowel Dis."},{"key":"3919_CR45","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00535-023-01983-y","volume":"58","author":"S Shinzaki","year":"2023","unstructured":"S. Shinzaki, T. Sato, H. Fukui, Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammation. J. Gastroenterol. 58, 598\u2013599 (2023). https:\/\/doi.org\/10.1007\/s00535-023-01983-y","journal-title":"J. Gastroenterol."},{"key":"3919_CR46","doi-asserted-by":"publisher","first-page":"k872","DOI":"10.1136\/bmj.k872","volume":"360","author":"D Abrahami","year":"2018","unstructured":"D. Abrahami, A. Douros, H. Yin et al. Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study. BMJ 360, k872 (2018). https:\/\/doi.org\/10.1136\/bmj.k872","journal-title":"BMJ"},{"key":"3919_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/ecco-jcc\/jjaa136","volume":"15","author":"CH Tseng","year":"2021","unstructured":"C.H. Tseng, Metformin use is associated with a lower risk of inflammatory bowel disease in patients with type 2 diabetes Mellitus. J. Crohns Colitis 15, 64\u201373 (2021). https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa136","journal-title":"J. Crohns Colitis"},{"key":"3919_CR48","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.2337\/dc13-0199","volume":"36","author":"K Timper","year":"2013","unstructured":"K. Timper, P. Hruz, C. Beglinger, M.Y. Donath, Infliximab in the treatment of Crohn disease and type 1 diabetes. Diab. Care 36, e90\u2013e91 (2013). https:\/\/doi.org\/10.2337\/dc13-0199","journal-title":"Diab. Care"},{"key":"3919_CR49","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/rheumatology\/kel322","volume":"46","author":"JG Boulton","year":"2007","unstructured":"J.G. Boulton, J.T. Bourne, Unstable diabetes in a patient receiving anti-TNF-alpha for rheumatoid arthritis. Rheumatology 46, 178\u2013179 (2007). https:\/\/doi.org\/10.1093\/rheumatology\/kel322","journal-title":"Rheumatology"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03919-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03919-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03919-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T22:04:25Z","timestamp":1731449065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03919-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3919"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03919-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"22 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No ethical approval from an ethics committee or Equator Network checklist was necessary as our study did not involve any human or animal research or observational studies. Our investigation utilized Mendelian randomization analysis and draw data from open databases. All of the projects and datasets cited in our study were approved by the respective ethics committees of the corresponding published articles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and Consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}